142 related articles for article (PubMed ID: 19552531)
1. Decreased urinary secretion of belotecan in folic acid-induced acute renal failure rats due to down-regulation of Oat1 and Bcrp.
Jin QR; Shim WS; Choi MK; Tian GY; Song IS; Yang SG; Kim DD; Chung SJ; Shim CK
Xenobiotica; 2009 Oct; 39(10):711-21. PubMed ID: 19552531
[TBL] [Abstract][Full Text] [Related]
2. JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2013 Sep; 271(2):285-95. PubMed ID: 23707770
[TBL] [Abstract][Full Text] [Related]
3. Changes in expression of renal Oat1, Oat3 and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats.
Liu T; Meng Q; Wang C; Liu Q; Guo X; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2012 Nov; 264(3):423-30. PubMed ID: 22992436
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.
Schneider R; Sauvant C; Betz B; Otremba M; Fischer D; Holzinger H; Wanner C; Galle J; Gekle M
Am J Physiol Renal Physiol; 2007 May; 292(5):F1599-605. PubMed ID: 17244891
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injury.
Bischoff A; Bucher M; Gekle M; Sauvant C
Am J Nephrol; 2014; 40(1):1-11. PubMed ID: 24943263
[TBL] [Abstract][Full Text] [Related]
6. Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome.
Schneider R; Meusel M; Renker S; Bauer C; Holzinger H; Roeder M; Wanner C; Gekle M; Sauvant C
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1614-21. PubMed ID: 19794109
[TBL] [Abstract][Full Text] [Related]
7. Oat1/3 restoration protects against renal damage after ischemic AKI.
Schneider R; Meusel M; Betz B; Held C; Möller-Ehrlich K; Büttner-Herold M; Wanner C; Gekle M; Sauvant C
Am J Physiol Renal Physiol; 2015 Feb; 308(3):F198-208. PubMed ID: 25391897
[TBL] [Abstract][Full Text] [Related]
8. Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters.
Wong CC; Barron D; Orfila C; Dionisi F; Krajcsi P; Williamson G
Mol Nutr Food Res; 2011 Jul; 55(7):979-88. PubMed ID: 21538853
[TBL] [Abstract][Full Text] [Related]
9. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
10. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
11. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.
Takahara N; Saga T; Inubushi M; Kusuhara H; Seki C; Ito S; Oyama N; Yokoyama O; Sugiyama Y; Fujibayashi Y
Nucl Med Biol; 2013 Jul; 40(5):643-50. PubMed ID: 23618840
[TBL] [Abstract][Full Text] [Related]
12. Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells.
Li H; Jin HE; Kim W; Han YH; Kim DD; Chung SJ; Shim CK
Pharm Res; 2008 Nov; 25(11):2601-12. PubMed ID: 18654741
[TBL] [Abstract][Full Text] [Related]
13. Effect of JBP485 on obstructive jaundice is related to regulation of renal Oat1, Oat3 and Mrp2 expression in ANIT-treated rats.
Liu T; Guo X; Meng Q; Wang C; Liu Q; Sun H; Ma X; Kaku T; Liu K
Peptides; 2012 Jul; 36(1):78-85. PubMed ID: 22521734
[TBL] [Abstract][Full Text] [Related]
14. Impact of the induced organic anion transporter 1 (Oat1) renal expression by furosemide on the pharmacokinetics of organic anions.
Severin MJ; Hazelhoff MH; Bulacio RP; Mamprin ME; Brandoni A; Torres AM
Nephrology (Carlton); 2017 Aug; 22(8):642-648. PubMed ID: 27282888
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of rat renal cortical organic anion transporter (OAT1 and OAT3) expression in response to ischemia/reperfusion injury.
Zhang R; Yang X; Li J; Wu J; Peng WX; Dong XQ; Zhou SF; Yu XQ
Am J Nephrol; 2008; 28(5):772-83. PubMed ID: 18441523
[TBL] [Abstract][Full Text] [Related]
17. Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats.
Shibayama Y; Ushinohama K; Ikeda R; Yoshikawa Y; Motoya T; Takeda Y; Yamada K
Cancer Sci; 2006 Nov; 97(11):1260-6. PubMed ID: 16925582
[TBL] [Abstract][Full Text] [Related]
18. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction.
Villar SR; Brandoni A; Anzai N; Endou H; Torres AM
Kidney Int; 2005 Dec; 68(6):2704-13. PubMed ID: 16316345
[TBL] [Abstract][Full Text] [Related]
20. Investigating the enteroenteric recirculation of apixaban, a factor Xa inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats.
Zhang D; Frost CE; He K; Rodrigues AD; Wang X; Wang L; Goosen TC; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):906-15. PubMed ID: 23386703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
